Gan & Lee Pharmaceuticals.
SSE:603087.SS
55.83 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 902.778 | 2,442.709 | 2,890.267 | 3,305.708 | 2,824.812 | 483.217 | 593.53 | 817.314 | 535.032 | 112.487 | 245.496 | 232.05 |
| Short Term Investments
| 1,500.497 | 2,410.43 | 1,635.95 | 1,624.183 | 787.05 | 1,058.272 | 584.7 | 435.5 | 225 | 351.219 | 0 | 0 |
| Cash and Short Term Investments
| 2,403.275 | 4,853.138 | 4,526.217 | 4,929.891 | 3,611.862 | 1,541.489 | 593.53 | 817.314 | 535.032 | 112.487 | 245.496 | 232.05 |
| Net Receivables
| 248.566 | 388.862 | 189.568 | 934.663 | 827.345 | 847.53 | 826.578 | 476.81 | 380.091 | 0 | 227.703 | 175.846 |
| Inventory
| 1,052.907 | 860.506 | 648.646 | 651.329 | 493.482 | 471.349 | 389.133 | 212.319 | 145.975 | 123.186 | 79.898 | 80.814 |
| Other Current Assets
| 86.111 | 73.243 | 299.706 | 354.56 | 1,026.924 | 249.73 | 672.314 | 463.832 | 253.541 | 351.402 | 22.241 | 25.793 |
| Total Current Assets
| 3,790.858 | 6,175.75 | 5,664.136 | 6,870.443 | 5,959.614 | 3,110.098 | 2,444.09 | 1,970.275 | 1,314.64 | 847.619 | 575.338 | 505.634 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 3,882.039 | 3,915.041 | 3,661.337 | 2,595.37 | 2,149.002 | 1,890.302 | 1,637.279 | 1,391.31 | 971.921 | 782.758 | 246.817 | 128.341 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 1,190.872 | 1,091.188 | 1,026.043 | 872.485 | 769.623 | 591.334 | 422.841 | 214.486 | 170.05 | 169.252 | 170.053 | 167.762 |
| Goodwill and Intangible Assets
| 1,190.872 | 1,091.188 | 1,026.043 | 872.485 | 769.623 | 591.334 | 422.841 | 214.486 | 170.05 | 169.252 | 170.053 | 167.762 |
| Long Term Investments
| -991.756 | 334.658 | -1,605.95 | -1,392.825 | -321.003 | -696.069 | 0 | 0 | 0 | 0 | 0 | -0 |
| Tax Assets
| 206.935 | 168.953 | 138.25 | 30.802 | 14.928 | 1,073.64 | 3.449 | 11.086 | 5.051 | 6.193 | 9.335 | 6.782 |
| Other Non-Current Assets
| 3,963.969 | 29.434 | 1,723.096 | 1,876.887 | 935.286 | 57.376 | 187.221 | 156.198 | 142.237 | 5.332 | 200.909 | 24.028 |
| Total Non-Current Assets
| 8,252.058 | 5,539.274 | 4,942.776 | 3,982.72 | 3,547.835 | 2,916.583 | 2,250.79 | 1,773.08 | 1,289.259 | 963.535 | 627.115 | 326.912 |
| Total Assets
| 12,042.916 | 11,715.023 | 10,606.912 | 10,853.163 | 9,507.449 | 6,026.681 | 4,694.88 | 3,743.355 | 2,603.899 | 1,811.155 | 1,202.453 | 832.546 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 129.129 | 105.542 | 44.693 | 37.741 | 17.814 | 30.65 | 39.333 | 31.214 | 36.771 | 14.632 | 6.379 | 2.018 |
| Short Term Debt
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.05 | 19.028 | 2 |
| Tax Payables
| 11.191 | 1.421 | 14.413 | 129.688 | 66.741 | 156.656 | 106.854 | 70.147 | 61.597 | 37.285 | 25.82 | 22.101 |
| Deferred Revenue
| 0 | 0 | 68.729 | 439.721 | 381.999 | 298.513 | 106.854 | 267.526 | 192.768 | 147.368 | 96.209 | 55.637 |
| Other Current Liabilities
| 660.811 | 666.487 | 753.931 | 281.539 | 256.852 | 270.914 | 208.117 | 234.451 | 173.11 | -11.285 | -24.482 | -19.978 |
| Total Current Liabilities
| 801.132 | 773.449 | 813.037 | 485.531 | 409.85 | 458.221 | 354.303 | 335.811 | 271.478 | 188.049 | 122.953 | 61.778 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 3.306 | 5.447 | 8.327 | 12.166 | 0 | 0.683 | 0.082 | 0 | 0 | 60.82 | 0 | 0.261 |
| Deferred Revenue Non-Current
| 168.924 | 179.626 | 187.635 | 141.977 | 125.769 | 71.067 | 65.91 | 71.905 | 73.276 | 72.192 | 41.108 | 37.286 |
| Deferred Tax Liabilities Non-Current
| 12.111 | 0 | 0 | 36.147 | 31.781 | 25.913 | 3.889 | -0.282 | -3.309 | 0 | -0.116 | 0 |
| Other Non-Current Liabilities
| 2.973 | 13.995 | 12.274 | 10.199 | 1.69 | 0 | 0 | 0 | 3.309 | 76.539 | 0 | 0 |
| Total Non-Current Liabilities
| 187.314 | 199.068 | 208.236 | 200.49 | 159.241 | 97.662 | 69.881 | 72.186 | 76.585 | 137.359 | 41.224 | 37.547 |
| Total Liabilities
| 988.446 | 972.517 | 1,021.273 | 686.021 | 569.091 | 555.883 | 424.184 | 407.998 | 348.063 | 325.408 | 164.177 | 99.326 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 601.065 | 594.162 | 565.653 | 561.54 | 561.54 | 360.9 | 360.9 | 360.9 | 335 | 335 | 335 | 335 |
| Retained Earnings
| 6,758.721 | 6,568.056 | 6,233.537 | 6,841.515 | 5,613.376 | 4,743.655 | 3,544.25 | 2,610.284 | 1,637.43 | 943.152 | 538.309 | 265.24 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 3.817 | 276.28 | 321.169 | 320.523 | 615.79 | 323.563 | 322.188 | 0.548 | 0.077 | 0 | 0 |
| Other Total Stockholders Equity
| 3,694.684 | 3,576.471 | 2,786.612 | 2,767.69 | 2,765.155 | 364.221 | 396.346 | 42.147 | 283.017 | 207.663 | 165.082 | 132.934 |
| Total Shareholders Equity
| 11,054.471 | 10,742.506 | 9,585.802 | 10,167.305 | 8,938.52 | 5,470.96 | 4,270.859 | 3,335.519 | 2,255.995 | 1,485.892 | 1,038.392 | 733.175 |
| Total Equity
| 11,054.471 | 10,742.506 | 9,585.64 | 10,167.142 | 8,938.358 | 5,470.798 | 4,270.697 | 3,335.357 | 2,255.836 | 1,485.747 | 1,038.275 | 733.22 |
| Total Liabilities & Shareholders Equity
| 12,042.916 | 11,715.023 | 10,606.912 | 10,853.163 | 9,507.449 | 6,026.681 | 4,694.88 | 3,743.355 | 2,603.899 | 1,811.155 | 1,202.453 | 832.546 |